GlassScriptPhysician profile
Richard D Stone
NPI 1417976119
$1,204.93
in general payments reported to CMS, 2019-2025
18 companies · $79.59 in 2025
The $79.59 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $112 · 2021: $196 · 2022: $293 · 2023: $206 · 2024: $92.14 · 2025: $79.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $206.63 | 2019-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $174.52 | 2019-2022 | |
| Neos Therapeutics, LP | $162.01 | 2019-2024 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Tris Pharma INC | $140.42 | 2019-2022 | |
| Glaxosmithkline, LLC. | $97.77 | 2020-2025 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $92.62 | 2019-2023 | Proquad, Vaxneuvance, Gardasil 9 |
| Corium, LLC | $64.39 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $56.74 | 2022-2023 | Flumist Quadrivalent |
| Supernus Pharmaceuticals, INC. | $40.43 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $37.75 | 2025 | Jornay Pm |
| Acadia Pharmaceuticals INC | $23.88 | 2025 | Daybue |
| Alk-Abello, INC | $17.92 | 2023 | Grastek, Odactra, Ragwitek |
| Pfizer INC. | $17.48 | 2021 | |
| Vertical Pharmaceuticals, LLC | $17.36 | 2019 | |
| Sobi, INC | $15.67 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $14.09 | 2020 | |
| Kaleo, INC. | $13.90 | 2022 | |
| Shire North American Group INC | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.